UK markets close in 3 hours 32 minutes

Edgewise Therapeutics, Inc. (EWTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
20.34+0.82 (+4.20%)
At close: 04:00PM EDT
20.34 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.90B
Enterprise value 1.59B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)5.96
Enterprise value/revenue N/A
Enterprise value/EBITDA -14.08

Trading information

Stock price history

Beta (5Y monthly) 0.15
52-week change 3108.83%
S&P500 52-week change 325.77%
52-week high 320.90
52-week low 35.12
50-day moving average 316.95
200-day moving average 310.93

Share statistics

Avg vol (3-month) 3735.61k
Avg vol (10-day) 3678.82k
Shares outstanding 593.41M
Implied shares outstanding 693.41M
Float 851.83M
% held by insiders 10.46%
% held by institutions 1100.48%
Shares short (15 Apr 2024) 45.76M
Short ratio (15 Apr 2024) 47.57
Short % of float (15 Apr 2024) 49.08%
Short % of shares outstanding (15 Apr 2024) 46.17%
Shares short (prior month 15 Mar 2024) 44.48M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-20.22%
Return on equity (ttm)-30.10%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -112.81M
Net income avi to common (ttm)-100.16M
Diluted EPS (ttm)-1.57
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)318.39M
Total cash per share (mrq)3.42
Total debt (mrq)5.41M
Total debt/equity (mrq)1.70%
Current ratio (mrq)19.50
Book value per share (mrq)4.53

Cash flow statement

Operating cash flow (ttm)-91.95M
Levered free cash flow (ttm)-61.66M